Drug-induced states of nephrogenic diabetes insipidus.
D001127:Arginine Vasopressin / Q000009:adverse effects / Q000031:analogs & derivatives; D003078:Colchicine / Q000009:adverse effects; D000242:Cyclic AMP / Q000378:metabolism; D003520:Cyclophosphamide / Q000009:adverse effects / Q000031:analogs & derivatives; D011431:Dextropropoxyphene / Q000009:adverse effects; D003919:Diabetes Insipidus / Q000139:chemically induced* / Q000378:metabolism; D004231:Diuresis / Q000187:drug effects; D006801:Humans; D007684:Kidney Tubules; D008094:Lithium / Q000009:adverse effects; D008733:Methoxyflurane / Q000009:adverse effects; D009997:Osmotic Pressure; D013453:Sulfonylurea Compounds / Q000009:adverse effects; D013754:Tetracyclines / Q000009:adverse effects; D014667:Vasopressins / Q000378:metabolism; D014748:Vinca Alkaloids / Q000009:adverse effects; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D013453:Sulfonylurea Compounds; D013754:Tetracyclines; D014748:Vinca Alkaloids; D014667:Vasopressins; D001127:Arginine Vasopressin; D008733:Methoxyflurane; D003520:Cyclophosphamide; D008094:Lithium; D000242:Cyclic AMP; D011431:Dextropropoxyphene; D003078:Colchicine